Table 1.
Variables | Frequency (n) | Percentage (%) |
---|---|---|
Sex (n = 2555) | ||
Female | 845 | 33.07 |
Male | 1710 | 66.93 |
Age (years) (n = 2555) | ||
≤18 | 125 | 4.89 |
19–28 | 555 | 21.72 |
29–38 | 940 | 36.79 |
39–48 | 559 | 21.88 |
49–58 | 230 | 9.00 |
59+ | 146 | 5.71 |
CXR status (n = 891) | ||
Normal | 26 | 2.92 |
Abnormal | 865 | 97.08 |
CXR features (n = 865) | ||
Cavitation | 359 | 41.50 |
Effusion | 55 | 6.36 |
Fibrosis | 234 | 27.05 |
Infiltration | 152 | 17.57 |
Lung destruction | 65 | 7.51 |
Zone treatment unit (n = 2400) | ||
SW | 1043 | 43.46 |
SS | 361 | 15.04 |
SE | 141 | 5.88 |
NE | 127 | 5.29 |
NC | 343 | 14.29 |
NW | 385 | 16.04 |
DR-TB category (n = 1897) | ||
MDR | 1165 | 61.41 |
RIF Resistant | 176 | 9.28 |
Mono-DR | 527 | 27.78 |
Poly-DR | 29 | 1.53 |
Number of previous Treatment (n = 823) | ||
Once | 302 | 36.70 |
Twice | 411 | 49.94 |
3 + | 110 | 13.37 |
Patient group (n = 2477) | ||
Previously treated | 1910 | 77.11 |
New | 567 | 22.89 |
HIV Status (n = 1303) | ||
Negative | 998 | 76.59 |
Positive | 305 | 23.41 |
Diagnosis type (n = 2523) | ||
Clinical | 283 | 11.22 |
Bacteriological confirmed | 2240 | 88.78 |
Abbreviations: SW (South West), SS (South South), SE (South East), NE (North East), NC (North Central), NW (North West), HIV (Human Immunodeficiency Virus), DR-TB (Drug-Resistant Tuberculosis).